Earnings Feed
Sign Up
Home/Filings/3/0001104659-21-122078
3//SEC Filing

Dexxon Holdings Ltd. 3

Accession 0001104659-21-122078

CIK 0001635088other
View on SEC.govCompany Profile

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 5:02 PM ET

Size

7.2 KB

Accession

0001104659-21-122078

Insider Transaction Report

Form 3
Period: 2021-10-01
Roivant Sciences Ltd.ROIV
Dexxon Holdings Ltd.
10% Owner
Holdings

  • Common Shares

    98,809,158
Dexcel Pharma Technologies Ltd.
10% Owner
Holdings

  • Common Shares

    98,809,158
Oren Dan
10% Owner
Holdings

  • Common Shares

    98,809,158
Footnotes (1)
  • [F1]Dexcel Pharma Technologies Ltd. ("Dexcel") is the direct beneficial holder of 643,845 common shares. Dexxon Holdings Ltd. ("Dexxon") is the direct beneficial holder of 98,165,313 common shares. Dan Oren is the Executive Chairman of Dexcel and the sole director of Dexxon and is ultimately the sole shareholder of each entity.

Documents

1 file

Issuer

Roivant Sciences Ltd.

CIK 0001635088

→
Entity typeother
IncorporatedIsrael

Related Parties

1
  • filerCIK 0001636684

Filing Metadata

Form type
3
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 5:02 PM ET
Size
7.2 KB
View on SEC.gov